WASHINGTON: The United States regulator hopes to rule Wednesday at the authorization of the booster dose of the modern vaccine and Johnson & Johnson Covid-19, a Food and Dress Administration (FDA) official at a government meeting.
Fink FDA Doran memorizes “some of today’s announcements”, which is expected to include allowing mixing and matching the Covid-19 booster dose among three US producers – Pfizer, Moderna and J & J.
Fink appears at a meeting of vaccines organized by the centers Control and prevention of disease, which is expected to make FDA’s decision and make their own recommendations on Thursday.
Some million Americans have got a third shot to increase the Covid-19 vaccine Pfizer.
Last week, the FDA independent expert panel in a round voice recommended expanding a booster campaign to include a two-dose vaccine recipient of two doses and one shot J & J vaccine.
Most experts also agreed that using different booster brands appear safe and effectively to improve protection.
The FDA is not required to follow group advice, even though it generally does it.
“The FDA is very busy since Friday wrapping our reviews and work towards authorization” from the vaccine application, Fink said, a deputy director in the FDA vaccine division.
Booster recommendations will not be official until after the CDC Director confirms who should get it and when.